Medicare Wastes $3.6 Billion Annually on Low-Value Care, Study Finds
New study reveals Medicare spends $3.6 billion annually on low-value medical services, with $800M in patient costs. Policy changes could reduce waste and improve value.
CMS Proposes 2026 Medicare Physician Fee Schedule With Focus on Value and Telehealth
CMS's 2026 Medicare Physician Fee Schedule proposal emphasizes value-based payment increases, expanded telehealth flexibilities, new chronic care payment models, and significant Medicare spending reductions for skin substitutes.
Legislative Changes Delay Medicare Drug Price Negotiations for Expensive Cancer Medications
Recent Republican-led legislative changes delay Medicare drug price negotiations for costly cancer treatments, maintaining high patient costs and impacting seniors and disabled Americans.
CMS Medicare Learning Network Web-Based Training Supports Provider Education
CMS offers a range of Medicare Learning Network web-based training courses for providers covering billing, coding, fraud prevention, and compliance. Courses are self-paced but do not provide continuing education credits. Subscribe to MLN Connects® for updates.
CMS Revisits GLP-1 Drug Coverage for Obesity in Medicare, Medicaid Pilot
CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.
Trump Administration Proposes Medicare, Medicaid Pilot for GLP-1 Weight Loss Drugs
The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.
Medicare 2026 Rate Increases, Hospital Efficiency Push, and AI Advances in Healthcare
Explore the 2026 Medicare payment updates for hospice, rehab, and psychiatric care, hospital efficiency initiatives amid rising costs, and growing use of agentic AI in healthcare settings.
Medicare Wastes $4.4B on Low-Value Tests for Older Adults, Study Finds
Study reveals Medicare spends $4.4 billion annually on low-value tests and procedures in older adults, urging evidence-based reforms to reduce waste and enhance care quality.
2025 Medicare Market Updates: UnitedHealthcare Market Exits, Drug Costs, and Rural Hospital Legislation
Explore the latest developments in Medicare for 2025 including UnitedHealthcare's market exits, anticipated drug price increases, new rural hospital funding legislation, and changes to Medicare Savings Programs affecting coverage and costs.
AMA Report Highlights Market Concentration Among PBMs and Calls for Greater Transparency
The AMA report reveals high market concentration among pharmacy benefit managers (PBMs), vertical integration with insurers, and calls for increased transparency and regulatory reforms to control drug prices and enhance competition.